Author

Xin Hu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Plan-level and provider-level variation in systemic therapy receipt among Medicare Advantage beneficiaries with advanced cancer.

79 Background: Prompt initiation of systemic therapy is a critical determinant of survival in advanced cancer. Medicare Advantage (MA) plans commonly employ prior authorization, which may affect timely systemic therapy initiation. Moreover, healthcare providers may differ in their capacity to navigate these req...

Xin Hu, Youngmin Kwon, Bo-Shen Jiao et al. · JCO Oncology Practice · 0 citations

Open access Oct 2026

Access to guideline-recommended supportive oncology medications in Medicare Part D.

328 Background: Supportive care medications are central to oncologic outcomes, yet unlike antineoplastic agents protected under Medicare Part D's six protected-class rules, supportive care agents remain subject to plan-level formulary and utilization management policies without equivalent federal protection. Th...

Yi-Xin Tang, Charles Jiang, Chuan Angel Lu et al. · JCO Oncology Practice · 0 citations

Review Sep 2026

Association of Area-level Broadband Access and Non-Small Cell Lung Cancer Diagnosis and Guideline-Concordant Care in the US.

Higher area-level broadband access was associated with better NSCLC outcomes, especially in non-metropolitan areas during the pandemic, and increased broadband access, combined with telehealth waivers during the pandemic may have supported greater access to and continuity of high-quality cancer care.

Qin-Jin Fan, Mu-Wu Xu, Margaret Katana Ogongo et al. · Cancer Epidemiology, Biomark... · 0 citations